Citadel Advisors’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.25M | Hold |
412,531
| – | – | ﹤0.01% | 3093 |
|
2025
Q1 | $1.76M | Sell |
412,531
-615,003
| -60% | -$2.62M | ﹤0.01% | 2715 |
|
2024
Q4 | $5.43M | Buy |
1,027,534
+347,023
| +51% | +$1.83M | ﹤0.01% | 1732 |
|
2024
Q3 | $1.25M | Buy |
680,511
+15,139
| +2% | +$27.7K | ﹤0.01% | 2907 |
|
2024
Q2 | $1.38M | Buy |
665,372
+639,424
| +2,464% | +$1.33M | ﹤0.01% | 2759 |
|
2024
Q1 | $104K | Sell |
25,948
-12,087
| -32% | -$48.5K | ﹤0.01% | 5066 |
|
2023
Q4 | $71.1K | Buy |
38,035
+15,892
| +72% | +$29.7K | ﹤0.01% | 4990 |
|
2023
Q3 | $37K | Buy |
22,143
+12,135
| +121% | +$20.3K | ﹤0.01% | 5174 |
|
2023
Q2 | $23.9K | Sell |
10,008
-36,179
| -78% | -$86.5K | ﹤0.01% | 5208 |
|
2023
Q1 | $143K | Buy |
46,187
+31,339
| +211% | +$97.2K | ﹤0.01% | 4767 |
|
2022
Q4 | $39.8K | Sell |
14,848
-155,674
| -91% | -$417K | ﹤0.01% | 5354 |
|
2022
Q3 | $505K | Sell |
170,522
-72,049
| -30% | -$213K | ﹤0.01% | 4070 |
|
2022
Q2 | $711K | Sell |
242,571
-163,677
| -40% | -$480K | ﹤0.01% | 3773 |
|
2022
Q1 | $2.08M | Sell |
406,248
-22,118
| -5% | -$113K | ﹤0.01% | 2972 |
|
2021
Q4 | $2.89M | Buy |
428,366
+81,935
| +24% | +$553K | ﹤0.01% | 2655 |
|
2021
Q3 | $2.4M | Buy |
346,431
+4,410
| +1% | +$30.5K | ﹤0.01% | 2796 |
|
2021
Q2 | $3.33M | Buy |
342,021
+100,507
| +42% | +$979K | ﹤0.01% | 2629 |
|
2021
Q1 | $3.8M | Buy |
+241,514
| New | +$3.8M | ﹤0.01% | 2434 |
|
2020
Q1 | – | Sell |
-1,174
| Closed | -$19K | – | 5292 |
|
2019
Q4 | $19K | Buy |
+1,174
| New | +$19K | ﹤0.01% | 4514 |
|
2019
Q3 | – | Sell |
-1,051
| Closed | -$17K | – | 5121 |
|
2019
Q2 | $17K | Buy |
+1,051
| New | +$17K | ﹤0.01% | 4513 |
|
2018
Q2 | – | Sell |
-452
| Closed | -$45K | – | 4569 |
|
2018
Q1 | $45K | Buy |
+452
| New | +$45K | ﹤0.01% | 3761 |
|
2017
Q2 | – | Sell |
-312
| Closed | -$22K | – | 4152 |
|
2017
Q1 | $22K | Buy |
+312
| New | +$22K | ﹤0.01% | 3511 |
|